PUBLISHER: The Business Research Company | PRODUCT CODE: 1942658
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942658
Dental biomaterials encompass biological and biosynthetic products employed in the treatment of tooth decay, damage, fractures, and the restoration of bones, soft tissues, and periodontal structures in the field of dentistry.
The primary types of dental biomaterials include metallic biomaterials, ceramic biomaterials, polymeric biomaterials, metal-ceramic biomaterials, natural biomaterials, and composite biomaterials. Metallic biomaterials find frequent application in joint replacements, dental implants, orthopedic fixations, and stents, providing internal support to biological tissues. Various types of bone graft materials, such as allograft, xenograft, and synthetic options, are utilized. These biomaterials are applied in orthodontics, implantology, prosthodontics, and other dental procedures. Dental biomaterials are commonly used in dental hospitals and clinics, dental laboratories, dental academies, research institutes, and dental product manufacturing.
Tariffs are impacting the dental biomaterials market by increasing costs of imported ceramics, specialty polymers, metal alloys, and processing equipment used in implants and restorations. Dental manufacturers and laboratories in North America and Europe are most affected due to dependence on imported raw materials, while Asia-Pacific faces cost pressure on export-oriented biomaterial production. These tariffs are raising material costs and affecting pricing strategies. However, they are also encouraging domestic material sourcing, regional manufacturing expansion, and innovation in alternative biomaterial formulations.
The dental biomaterials market research report is one of a series of new reports from The Business Research Company that provides dental biomaterials market statistics, including dental biomaterials industry global market size, regional shares, competitors with a dental biomaterials market share, detailed dental biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the dental biomaterials industry. This dental biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The dental biomaterials market size has grown strongly in recent years. It will grow from $9.01 billion in 2025 to $9.79 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing prevalence of dental disorders, expansion of restorative dental procedures, growth in cosmetic dentistry demand, rising adoption of implant-based treatments, availability of advanced dental materials.
The dental biomaterials market size is expected to see strong growth in the next few years. It will grow to $13.42 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing focus on aesthetic dental outcomes, rising adoption of digital dentistry workflows, growing demand for minimally invasive procedures, expansion of dental tourism, advancements in biomaterial engineering. Major trends in the forecast period include increasing adoption of zirconia and ceramic materials, rising demand for biocompatible dental solutions, growing use of cad/cam compatible biomaterials, expansion of composite and hybrid biomaterial usage, enhanced focus on long-term oral compatibility.
The increasing prevalence of dental disorders is anticipated to drive the expansion of the dental biomaterials market in the coming years. Dental disorders refer to conditions that adversely affect the oral cavity. The growing incidence of these conditions is largely attributed to inadequate oral hygiene practices, which promote plaque accumulation and elevate the risk of cavities and periodontal diseases. Dental biomaterials play a vital role in addressing dental disorders by offering enhanced protection, supporting remineralization, and enabling bioactive prevention of oral health issues. For instance, in March 2025, according to the Office for Health Improvement and Disparities, during the 2023-2024 period, five-year-old schoolchildren living in the most deprived quintile of the United Kingdom were more than twice as likely to have experienced dentinal decay (32.2%) compared with those in the least deprived quintile (13.6%). Therefore, the rising burden of dental disorders is contributing to the growth of the dental biomaterials market.
Leading companies in the dental biomaterials market are introducing new products, such as growth factor-rich membranes, to expand their customer bases and boost revenue. A growth factor-rich membrane is a biomaterial that contains a concentrated mix of growth factors, cytokines, and other biological enhancers designed to facilitate optimal tissue regeneration and wound healing. For example, in October 2023, ZimVie, a US-based manufacturer of medical instruments, launched the Biotivity A/C Plus Membrane, a biomaterial rich in growth factors. This innovative membrane, sourced from human placental tissue, is notable in the market for its unique approach to dental procedures. Composed of growth factors, cytokines, chemokines, and hyaluronic acid, it enhances wound healing during jaw repair and reconstruction for dental implants. Importantly, the Biotivity A/C Plus Membrane undergoes minimal manipulation, preserving its natural properties, and is sterilized using the Excellion Process. Its antibiotic-free processing sets it apart from other A/C membranes available in the market.
In April 2023, Henry Schein Inc., a US-based provider of healthcare solutions for office-based dental and medical practitioners, acquired Biotech Dental S.A.S. for an undisclosed amount. This acquisition aims to establish a digital workflow that delivers a seamless experience for customers, improving case acceptance and enhancing clinical outcomes for practitioners. Biotech Dental S.A.S. is a French manufacturer of dental biomaterials.
Major companies operating in the dental biomaterials market are Straumann Group, Geistlich Biomaterials, Zimmer Biomet Holdings Inc., Dentsply Sirona Inc., 3M Company, Koninklijke DSM N.V., Kuraray Co Ltd., Henry Schein Inc., Mitsui Chemicals Inc., Ivoclar Vivadent AG, Bego Medical GmbH, Institut Straumann AG, BioHorizons IPH Inc., Nobel Biocare Services AG, ACE Surgical Supply Company Inc., Biomatlante, Align Technology Inc., Carestream Dental LLC, Datum Dental Ltd., VITA Zahnfabrik H Rauter Gr KG, Coltene Whaledent AG, DMG Chemisch-Pharmazeutische Fabrik GmbH, Heraeus Kulzer GmbH, Kavo Dental GmbH, Septodont Holding, Ultradent Products Inc., VOCO GmbH
North America was the largest region in the dental biomaterials market share in 2025. The regions covered in the dental biomaterials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the dental biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The dental biomaterials market consists of sales of dental cement, membranes, and soft tissue regeneration products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Dental Biomaterials Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses dental biomaterials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for dental biomaterials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dental biomaterials market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.